Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00042159 · ClinicalTrials.gov registry record · NA

Transcranial Magnetic Stimulation (TMS) Treatment for Patients With Persistent Auditory Hallucinations

A NA study of Schizophrenia and Hallucinations, sponsored by Yale University.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT00042159 is a NA study of Schizophrenia and Hallucinations that has completed, run by Yale University. The registered enrollment target is 50 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00042159, a NA study of Schizophrenia and Hallucinations, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the long-term effects of repetitive transcranial magnetic stimulation (rTMS) in patients with auditory hallucinations.

Conditions Studied

Schizophrenia Hallucinations

Interventions

  • DEVICE repetitive transcranial magnetic stimulation

Study Locations (1)

Connecticut

  • Yale-New Haven Psychiatric Hospital - New Haven

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2002-07
Est. Completion 2004-06
Phase NA

Sponsor

Yale University

1,492 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00042159

The ClinicalTrials.gov registry entry for NCT00042159 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (77% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Schizophrenia appearing as the primary indexed condition, and to 1 intervention - of which repetitive transcranial magnetic stimulation is the first listed.

NCT00042159 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT00042159 about?

NCT00042159 is a clinical study titled "Transcranial Magnetic Stimulation (TMS) Treatment for Patients With Persistent Auditory Hallucinations". This study will evaluate the long-term effects of repetitive transcranial magnetic stimulation (rTMS) in patients with auditory hallucinations.

What is the current status of trial NCT00042159?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2002-07. Estimated completion is 2004-06.

What conditions does trial NCT00042159 study?

This clinical trial studies the following conditions: Schizophrenia, Hallucinations.

What interventions are being tested in trial NCT00042159?

The interventions under investigation include: repetitive transcranial magnetic stimulation (DEVICE).

Who is sponsoring clinical trial NCT00042159?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00042159 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Schizophrenia

All registered trials for this condition

Hallucinations

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.